Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
34.85
+0.47 (1.37%)
Feb 21, 2025, 4:00 PM EST - Market closed

Surmodics Market Cap

Surmodics has a market cap or net worth of $498.22 million as of February 21, 2025. Its market cap has increased by 13.80% in one year.

Market Cap
498.22M
Enterprise Value
501.10M
1-Year Change
13.80%
Ranking
Category
Stock Price
$34.85

Market Cap Chart

Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $498.22M, an increase of 638.10%. That is a compound annual growth rate of 7.92%.

History

DateMarket Cap% Change
Feb 20, 2025491.50M-13.36%
Dec 31, 2024567.30M10.24%
Dec 29, 2023514.60M7.43%
Dec 30, 2022479.00M-28.45%
Dec 31, 2021669.50M12.48%
Dec 31, 2020595.20M6.04%
Dec 31, 2019561.30M-11.36%
Dec 31, 2018633.20M72.63%
Dec 29, 2017366.80M9.33%
Dec 30, 2016335.50M27.86%
Dec 31, 2015262.40M-7.67%
Dec 31, 2014284.20M-15.16%
Dec 31, 2013335.00M2.20%
Dec 31, 2012327.80M27.55%
Dec 30, 2011257.00M23.97%
Dec 31, 2010207.30M-47.64%
Dec 31, 2009395.90M-11.31%
Dec 31, 2008446.40M-54.99%
Dec 31, 2007991.70M73.25%
Dec 29, 2006572.40M-16.56%
Dec 30, 2005686.00M19.85%
Dec 31, 2004572.40M38.03%
Dec 31, 2003414.70M-16.41%
Dec 31, 2002496.10M-18.92%
Dec 31, 2001611.90M0.02%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.71B
UnitedHealth Group 429.24B
Novo Nordisk 391.83B
Johnson & Johnson 390.76B
AbbVie 356.74B
Abbott Laboratories 234.01B
AstraZeneca 229.50B
Merck & Co. 226.40B
Market Cap Rankings